Drug Shortage Report for ADVAIR
Report ID | 151138 |
Drug Identification Number | 02245126 |
Brand name | ADVAIR 125 |
Common or Proper name | fluticasone propionate and salmeterol pressurized inhalation, suspension |
Company Name | GLAXOSMITHKLINE INC |
Market Status | MARKETED |
Active Ingredient(s) | FLUTICASONE PROPIONATE SALMETEROL |
Strength(s) | 125MCG 25MCG |
Dosage form(s) | AEROSOL, METERED DOSE |
Route of administration | INHALATION INHALATION |
Packaging size | 1x120 |
ATC code | R03AK |
ATC description | ADRENERGICS, INHALANTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2021-12-09 |
Estimated end date | 2022-01-19 |
Actual end date | 2022-01-18 |
Shortage status | Resolved |
Updated date | 2022-01-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2022-01-19 | French | Compare |
v3 | 2022-01-19 | English | Compare |
v2 | 2021-12-14 | French | Compare |
v1 | 2021-12-14 | English | Compare |
Showing 1 to 4 of 4